Diuretics Market Report 2026

Diuretics Market Overview

• Diuretics market size has reached to $0.77 billion in 2025 • Expected to grow to $0.92 billion in 2030 at a compound annual growth rate (CAGR) of 3.7% • Growth Driver: Rising Cases Of Renal And Kidney Disorders Driving Market Growth Due To Increased Need For Fluid Management Therapies • Market Trend: Focus on Innovation In The Diuretics Market • North America was the largest region in 2025 and Middle East is the fastest growing region.

What Is Covered Under Diuretics Market?

Diuretic drugs refer to the drugs that help increase the flow of urine by reducing the concentration of sodium and chloride in the body. It helps the body eliminate salt (sodium) and water with these so-called ‘water tablets. Diuretic drugs include diuril, microzide, and indapamide. The main types of diuretics are osmotic diuretics, carbonic anhydrase inhibitors, loop diuretics, thiazides and thiazide-like diuretics, and aldosterone antagonists. An osmotic diuretic is a form of diuretic that prevents water and sodium from being reabsorbed. They are intravenously administered, pharmacologically inactive compounds. The different routes of administration include intravenous and oral, and they are used in hypertension, glaucoma, heart failure, and kidney stones. It is distributed through various channels, such as hospital pharmacies, independent pharmacies, retail pharmacies, drug stores, and online pharmacies.

What Is The Diuretics Market Growth Forecast?

The diuretics market size is expected to see steady growth in the next few years. It will grow to $0.92 billion in 2030 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to growth in chronic kidney disease cases, rising heart failure prevalence, expansion of primary healthcare access, improved treatment guidelines, increased geriatric population. Major trends in the forecast period include rising use in hypertension management, increased adoption of combination diuretic therapy, growth in generic diuretic drugs, expansion of outpatient treatment settings, improved formulations with reduced side effects.

What Is The Driver Of The Diuretics Market?

The increase in renal and kidney disorder cases is expected to drive the diuretics market going forward. Renal and kidney disorders impair the body’s ability to regulate fluid and electrolyte balance, often leading to conditions such as edema, hypertension, and fluid retention that require diuretics for effective management. The rise in kidney disorders can be attributed to changes in lifestyle such as the consumption of unhealthy food high in calcium and other minerals. The growing burden of kidney disorders supports the diuretics by increasing the demand for medications that can remove excess fluid, reduce swelling, and help control blood pressure in affected patients. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, an estimated 14% of U.S. adults, or around 35.5 million people, are believed to be living with chronic kidney diseases. Therefore, increase in renal and kidney disorder cases drives the growth of the diuretics industry.

Key Players In The Global Diuretics Market

Major companies operating in the diuretics market are Merck & Co. Inc., Meda Manufacturing GmbH, Pfizer Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Aton Pharma Inc., Boehringer Ingelheim International GmbH, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd, Validus Pharmaceuticals LLC, Actavis Generics, Paddock Laboratories LLC, Perrigo Pharmaceutical Company, Oak Pharmaceuticals Inc., Akron Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Aurobindo Pharma Limited, IPCA Laboratories Limited, Jubilant Cadista Pharmaceuticals Limited, Mylan N.V., Princeton Laboratories Inc., Sciegen Pharma Limited, Unichem Laboratories Limited, AstraZeneca plc, Bayer AG, Cipla Ltd, Fresenius Kabi AG, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd, Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.

Global Diuretics Market Trends and Insights

Major companies operating in the diuretics market are focusing on developing innovative products such as prescription medication to enhance treatment efficacy and reduce side effects for patients with conditions like hypertension and heart failure. Prescription medication refers to drugs that can only be obtained with a doctor's prescription, ensuring they are used appropriately for specific medical conditions under professional supervision. For instance, in January 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched a generic version of the diuretic Bumetanide Injection for the treatment of fluid retention and swelling associated with congestive heart failure and other conditions. This product is available in two formulations. 1 mg/4 mL single-dose vials and 2.5 mg/10 mL multi-dose vials, both containing a concentration of 0.25 mg/mL This injection is used to effectively treat edema (fluid retention) caused by conditions such as congestive heart failure, liver disease, and kidney disease, promoting increased urine production to alleviate symptoms like swelling and difficulty breathing.

What Are Latest Mergers And Acquisitions In The Diuretics Market?

In April 2025, Lupin Healthcare (UK) Limited, a UK-based provider of specialty and branded generic pharmaceutical products, acquired Renascience Pharma Limited for an undisclosed amount. With this acquisition, Lupin aims to extend its specialty branded pharmaceuticals portfolio and strengthen its commercial presence in the UK market. Renascience Pharma Limited is a UK-based provider of niche branded generics focused on infectious disease, pain management, and cardiology/nephrology products, including quinazoline-like diuretic.

What Defines the Diuretics Market?

The diuretics market consists of sales of diuril, microzide, and indapamide. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Diuretics Market Report 2026?

The diuretics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the diuretics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.